← Leaderboards
Lowell B Anthony
Tulane University Of Louisiana
$823,200
Attributed
$823,200
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $225K · FY2005–25$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$823,200 · 9
By mechanism
P30$764,857 · 2
M01$58,343 · 7
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Roy S Weiner$6,513,200
- Vivian A Fonseca$5,822,487
- William McKinnon$49,515
- Eugene A Woltering$73,643
- Timothy G Hammond$1,009,230
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchClinical TrialsDisciplineConduct Clinical TrialsClinical OncologyCancer InterventionCatchment AreaCancer PreventionClinical TranslationClinical CareClinical ProtocolsClinical Cancer CenterClinically RelevantCancer Center Support GrantCancer CenterCancer Clinical TrialCancer ControlAuthorityChargeCancer Research Center DirectorBasic ScienceBiometryCommittee Members
Grant awards (22)
Protocol Review and Monitoring System$73,622
P30 · FY2025 · CA · contact PI
Protocol Review and Monitoring System$67,175
P30 · FY2024 · CA · contact PI
Protocol Review and Monitoring System$224,973
P30 · FY2023 · CA · contact PI
Protocol Review and Monitoring System$70,361
P30 · FY2022 · CA · contact PI
Protocol Review and Monitoring System$70,363
P30 · FY2021 · CA · contact PI
Protocol Review and Monitoring System$70,363
P30 · FY2020 · CA · contact PI
Protocol Review and Monitoring System$70,363
P30 · FY2019 · CA · contact PI
Protocol Review and Monitoring System$70,363
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$15,118
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$13,345
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$12,500
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$6,311
P30 · FY2018 · CA · contact PI
STUDY TO EVALUATE THE EFFECT OF AGE AND RENAL FUNCTION OF OCTREOSCAN$8,549
M01 · FY2006 · RR · contact PI
SAFETY AND EFFICACY OF PTK787/ZK222584 IN PATIENTS WITH NEUROENDOCRINE CANCER$3,108
M01 · FY2006 · RR · contact PI
STUDY TO EVALUATE THE EFFECT OF AGE AND RENAL FUNCTION OF OCTREOSCAN$10,058
M01 · FY2005 · RR
Study to Evaluate the Effect of Age and Renal Function$10,780
M01 · FY2004 · RR
Clinical Trial With Thymitaq Administered to Patients$7,599
M01 · FY2004 · RR
Study Comparing Venofer Intravenously to No Iron Tx$7,069
M01 · FY2004 · RR
IODINE-131 ANTI-B1 ANTIBODY FOR NHL$0
M01 · FY2001 · RR
THERAPEUTIC INDIUM 111 PENTETREOTIDE IN SOMATOSTAIN RECEPTOR EXPRESSING CANCERS$0
M01 · FY2001 · RR
THERAPEUTIC INDIUM 111 PENTETREOTIDE IN SOMATOSTAIN RECEPTOR EXPRESSING CANCERS$11,180
M01 · FY2000 · RR
IODINE-131 ANTI-B1 ANTIBODY FOR NHL$0
M01 · FY2000 · RR